Xingnao Kaiqiao Acupuncture vs Electroacupuncture for Post-Stroke Upper Limb Recovery
XNKQ-RCT
Effectiveness of Xingnao Kaiqiao Acupuncture Compared to Electroacupuncture in Improving Upper Limb Function in Early Stroke Rehabilitation: A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a single-center interventional study conducted at the Ho Chi Minh City Hospital for Orthopedics and Rehabilitation, led by investigators from the University of Medicine and Pharmacy at Ho Chi Minh City. The study aims to evaluate the effectiveness of a specific acupuncture protocol (Xingnao Kaiqiao - Brain Awakening Acupuncture) in improving upper limb motor recovery in post-ischemic stroke patients during the early rehabilitation phase. Data collection has been completed, and the study is currently being registered on ClinicalTrials.gov to ensure research transparency, ethical compliance, and to facilitate future publication. The final results and publication will be updated once the study receives a registration number.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2025
CompletedFirst Posted
Study publicly available on registry
July 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJuly 31, 2025
January 1, 2025
9 months
July 13, 2025
July 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Fugl-Meyer Assessment of Upper Extremity (FMA-UE) Score
Change in FMA-UE score from baseline to 4 weeks post-treatment. The Fugl-Meyer Assessment for Upper Extremity (FMA-UE) is a validated scale that measures upper limb motor function in post-stroke patients. The scale ranges from 0 (severe impairment) to 66 (normal function). Higher scores indicate better recovery of motor function.
4 weeks
Secondary Outcomes (3)
Change in Barthel Index Score
4 weeks
Proportion of Participants Achieving MCID in FMA-UE
4 weeks
Proportion of Participants Achieving MCID in Barthel Index
4 weeks
Other Outcomes (2)
Incidence and Classification of Adverse Events
4 weeks
Patient Global Impression of Change (PGIC)
4 weeks
Study Arms (2)
Xingnao Kaiqiao Acupuncture
EXPERIMENTALParticipants in this group received Xingnao Kaiqiao (XNKQ) acupuncture based on the standardized protocol developed by Prof. Shi Xuemin, focusing on awakening the brain and opening the sensory orifices. Treatment was administered once daily for 5 days/week over 4 weeks.
Electroacupuncture
ACTIVE COMPARATORParticipants in this group received routine electroacupuncture therapy applied to standard upper-limb motor recovery acupoints. Treatment was administered once daily for 5 days/week over 4 weeks.
Interventions
Acupuncture procedure developed by Prof. Shi Xuemin. Key acupoints include DU26, PC6, SP6, LI4, and GV20, applied with rapid and penetrating stimulation. Arm(s): Xingnao Kaiqiao Acupuncture
Routine electroacupuncture using standard acupoints for hemiplegic upper limb rehabilitation, including LI15, LI11, SJ5, and LI4, with low-frequency electrical stimulation.
Eligibility Criteria
You may qualify if:
- Patients aged 40 to 80 years
- Diagnosed with ischemic or hemorrhagic stroke confirmed by CT or MRI
- Stroke onset between 1 and 6 months prior to enrollment
- Moderate to severe upper limb motor impairment (FMA-UE score between 20 and 60)
- Medically stable and able to attend treatment sessions 3 times per week
- Capable of understanding the study procedures and providing informed consent
You may not qualify if:
- History of severe cognitive impairment (MMSE score \< 20)
- Comorbidities that affect motor function (e.g., Parkinson's disease, multiple sclerosis)
- Severe aphasia or communication disorder that prevents assessment
- Botulinum toxin injection in the upper limb within the past 3 months
- Pacemaker or other contraindications to electroacupuncture
- Currently participating in another clinical trial
- Skin infections or local conditions at acupuncture sites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ho Chi Minh City Orthopedic and Rehabilitation Hospital
Ho Chi Minh City, Ho Chi Minh, 700000, Vietnam
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Minh-Anh Nguyen Ngo Le, M.D., Ph.D.
University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor was blinded to the treatment allocation to minimize assessment bias. Neither participants nor care providers were masked due to the nature of acupuncture interventions.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer, MD, PhD- Faculty of Traditional Medicine, University of Medicine and Pharmacy at Ho Chi Minh City
Study Record Dates
First Submitted
July 13, 2025
First Posted
July 22, 2025
Study Start
November 1, 2024
Primary Completion
July 20, 2025
Study Completion
August 1, 2025
Last Updated
July 31, 2025
Record last verified: 2025-01